Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	38.08B
Revenue (ttm)	6.30B
Net Income (ttm)	1.07B
Shares Out	359.15M
EPS (ttm)	2.98
PE Ratio	36.17
Forward PE	30.76
Dividend	1.10 (1.02%)
Ex-Dividend Date	Jun 26, 2025

Volume	5,985,311
Average Volume	10,544,846
Open	113.48
Previous Close	111.72
Day's Range	107.25 - 113.48
52-Week Range	59.90 - 125.50
Beta	0.23
RSI	47.32
Earnings Date	Oct 29, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,595
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2024, SHE:002821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.